THE BEST THERAPY FOR HELICOBACTER-PYLORI INFECTION - SHOULD EFFICACY OR SIDE-EFFECT PROFILE DETERMINE OUR CHOICE

被引:103
作者
DEBOER, WA [1 ]
TYTGAT, GNJ [1 ]
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT GASTROENTEROL,1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.3109/00365529509093298
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:401 / 407
页数:7
相关论文
共 61 条
  • [1] ATHERTON JC, 1994, GASTROENTEROLOGY, V106, pA42
  • [2] ATHERTON JC, 1994, GASTROENTEROLOGY, V106, pA41
  • [3] BALATSOS V, 1993, GASTROENTEROLOGY, V104, pA37
  • [4] BAYERDORFFER E, 1992, EUR J GASTROEN HEPAT, V4, P697
  • [5] BAYERDORFFER E, 1994, GASTROENTEROLOGY, V106, pA48
  • [6] SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI
    BAZZOLI, F
    ZAGARI, RM
    FOSSI, S
    POZZATO, P
    ALAMPI, G
    SIMONI, P
    SOTTILI, S
    RODA, A
    RODA, E
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (09) : 773 - 777
  • [7] METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI
    BECX, MCJM
    JANSSEN, AJHM
    CLASENER, HAL
    DEKONING, RW
    [J]. LANCET, 1990, 335 (8688) : 539 - 540
  • [8] BELL GD, 1992, ALIMENT PHARM THERAP, V6, P427
  • [9] BELL GD, 1992, ALIMENT PHARM THERAP, V6, P751
  • [10] BELL GD, 1991, EUR J GASTROEN HEPAT, P923